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ABSTRACT
The use of polyelectrolyte multilayer microcapsules as carriers for
fluorescent molecular probes is a prospective technique for monitoring
the physiological characteristics of animal vasculature and interstitial
environment in vivo. Polyelectrolytemicrocapsules havemany features
that favor their use as implantable carriers of optical sensors, but little
information is available on their interactionswith complex living tissues,
distribution or residence time following different routes of administration
in the body of vertebrates. Using the common fishmodel, the zebrafish
Danio rerio, we studied in vivo the distribution of non-biodegradable
microcapsules covered with polyethylene glycol (PEG) over time in the
adults and evaluated potential side effects of their delivery into the fish
bloodstream and muscles. Fluorescent microcapsules administered
into the bloodstream and interstitially (in concentrations that were
sufficient for visualization and spectral signal recording) both showed
negligible acute toxicity to the fishes during threeweeks of observation.
The distribution pattern of microcapsules delivered into the
bloodstream was stable for at least one week, with microcapsules
prevalent in capillaries-rich organs. However, after intramuscular
injection, the phagocytosis of the microcapsules by immune cells
was manifested, indicating considerable immunogenicity of the
microcapsules despite PEG coverage. The long-term negative
effects of chronic inflammation were also investigated in fish muscles
by histological analysis.
KEY WORDS: Fluorescent probes, In vivo sensing, Layer-by-layer,
Microencapsulated biomarkers
INTRODUCTION
Microencapsulation is a collection of techniques with great potential
for application in biosciences. One of the most promising methods
for microencapsulation is the template-assisted approach via layer-
by-layer (LbL) assembly of oppositely charged polyelectrolytes
(Decher, 1997; De Geest et al., 2006; Cui et al., 2014; Liu and
Picart, 2016; Vilela et al., 2017). This technique allows fast and
easy preparation of hollow microcapsules with a hydrophilic
semipermeable polymeric wall enclosing some functional
compound (Donath et al., 1998; Antipov et al., 2003; Volodkin
et al., 2004; Gaponik et al., 2003; De Geest et al., 2006). The LbL-
assembled microcapsules have two general types of potential
applications in medicine and biological research on whole
organisms. (1) Delivery of drugs and vaccines to target organs/
tissues; this requires some technological solutions for control of the
wall opening of capsules (De Geest et al., 2007, 2012; Esser-Kahn
et al., 2011; Skirtach et al., 2011; Dierendonck et al., 2012; Feng
et al., 2014; Gao et al., 2016). (2) Sensing of physiological
parameters in vivo (Ruckh and Clark, 2014; Cui et al., 2014; Gurkov
et al., 2016; Borvinskaya et al., 2017). This employment is based on
the properties of semipermeability and stability (at least on certain
time scales) of some types of polymeric shells.
Although drug delivery with polyelectrolyte microcapsules (PMs)
is currently the primary vector in the development of PM technology
(Antipina et al., 2014), monitoring of different physiological
characteristics in vivo also offers significant prospects.
Immobilization of optical molecular probes into PMs is an
emerging technique in implantable sensor design for several
reasons. The fluorescent molecular probes sensitive to certain
metabolites, ions (including H+, Na+ and Ca2+) and oxygen
radicals (Johnson and Spence, 2010) can have considerable toxicity
to the studied organism (Alford et al., 2009), and they dissolve in the
whole volume of internal fluids, which complicates acquisition of the
fluorescent signal. Packing of dyes into semipermeable shells of PMs
prevents their bioavailability and decreases toxicity; thus, the probes
are resistant to biodegradation and the fluorescent signal is
intensified. When applied in vivo, covering the PMs with a
polyethylene glycol-containing (PEG) polymer can significantly
decrease their aggregation and sticking to walls of blood capillaries,
which minimizes the toxicity from the PMs, and mimic PMs from
phagocytes at least during several hours (Wattendorf et al., 2008;
Knop et al., 2010; Sadovoy et al., 2012). Moreover, flexible and thin
walls of micron-sized PMs allow flexibility in small capillaries,
similar to that of blood cells, for distribution in the circulatory system.
Although the cytotoxicity of PMs has received considerable
attention (Wattendorf et al., 2008; De Koker et al., 2007; Minaeva
et al., 2017), their toxicity at the organism level, interaction with
complex living tissues and fate in organisms depending on the route
of administration remain poorly reported (Zhao et al., 2007; De
Koker et al., 2007, 2010; Sadovoy et al., 2012; Yi et al., 2014; Shao
et al., 2015; Voronin et al., 2017). Importantly, the most studies
report on distribution of microcapsules in certain organs or regions
of the body (mostly tumors), and lack analysis of microcapsule
behavior on the organism level. For the prospective applications ofReceived 2 October 2017; Accepted 24 November 2017
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PMs in diverse areas, the methodology of delivery and visualization
(for optical sensing) of PMs in different parts and organs of
vertebrate organisms must be developed and optimized.
This article provides the first practical steps toward a consistent
technique for implanting PMs with the PEG-containing coverage
(PMs-PEG) into adult zebrafish Danio rerio (Hamilton 1822). This
species is a common model for investigation of stress physiology and
metabolic disorders in vertebrates, and also is a traditional organism
in aquatic ecotoxicology (Pereira et al., 2016; Nguyen et al., 2013).
Because the zebrafish has a small and translucent body (transparent
strains are also developed), this fish is more suitable as a vertebrate
subject than adult rodents to study the distribution of fluorescent PMs.
Because our primary focus was the further application of PMs-PEG
for physiological measurements, stable non-biodegradable materials,
such as poly(allylamine hydrochloride) (PAH) and poly(sodium
4-styrenesulfonate) (PSS), were selected to form the semipermeable
wall of the PMs. In this study, we administered PMs-PEG to adult
D. rerio to investigate their distribution in tissues, stability, toxicity
and general side effects, aswell as to practice their visualization inside
the organism using different strategies of delivery. We examined the
intramuscular route of injection and introduction into the bloodstream
and recorded short-term and long-term in vivo effects of PMs-PEG on
the zebrafish organism.
RESULTS
Organism-level toxicity of PMs-PEG
In an earlier study, the toxicity of PMs-PEG to developing embryos
of D. rerio was low (Sadovoy et al., 2012). Based on our data, the
use of PMs-PEG in adult D. rerio also resulted in low acute side
effects. After intramuscular injection with different types of PMs-
PEG, nearly all fishes recovered fully and swam actively in their
holding tanks (<2% mortality, n=101; Table S1). We did not
observe delayed effects of the injections on survival in the control
group after 7 and 14 days (n=50 and 5, respectively).
After injection into the kidney (for implantation of PMs-PEG
into the bloodstream), the most deaths (10-15%) were registered
during the first few hours after the injection in both experimental
(n=119) and control groups (n=37) (Table S1). This mortality was
most likely associated with the trauma and stress caused by the
procedure. In general, fishes treated with PMs-PEG of an average
size of 5.1 µm had lower survival than fishes injected with
microcapsules approximately 2 μm in diameter, which had the
best survival. Among fishes that were injected with PMs-PEG
containing the dye FITC-BSA, the highest mortality during the
experiment was among fishes that received the largest concentration
of the microcapsules (approximately 4×106 µl), compared with
fishes injected with lower concentrations.
Based on the results, mortality was not significantly affected by
either route of administration of PMs-PEG, and therefore, these
PMs-PEG could be used for implanting of microcapsules in
experimental procedures.
Distribution of PMs-PEG in the bloodstream
After delivery into the fish bloodstream (by injection into renal
parenchyma or retro-orbital sinus), 3.9±0.9 µm (Fig. 1A) PMs-PEG
in the bloodstream immediately spread throughout the body (Fig. 2;
Figs S1-S4). Microscopy of dissected organs showed that within a
few minutes after the injection, fluorescent PMs-PEG reached the
heart, liver, gills, kidney, brain and other internal organs (Figs 2
and 3; Figs S1-S4). In the heart and big vessels, movement of
Fig. 1. Images and size profiles of prepared PMs-PEG containing FITC-BSA (used for investigation of distribution and stability). Median diameters are
approximately 4.0 µm (A) and 2.7 µm (B). Fluorescent images of PMs-PEG are obtained in green channel.
2
RESEARCH ARTICLE Biology Open (2018) 7, bio030015. doi:10.1242/bio.030015
B
io
lo
g
y
O
p
en
 by guest on July 16, 2019http://bio.biologists.org/Downloaded from 
free-floating PMs-PEG can be observed until the cardiac contraction
goes on.
PMs-PEG were observed in vasculature for many days (Fig. 2;
Figs S1-S4). Seven days following introduction of PMs-PEG, the
highest concentrations of microcapsules (after both retro-orbital and
intrarenal injections) were in the injection site and then in the gills
and head kidney (Figs S1C-F, S2A-B and S3). PMs-PEG were
relatively rare in the muscle tissue distant from the site of injection,
in the gonads and in the fin capillaries. Microcapsules continued to
be found in the fish heart one week after injection, indicating their
free circulation (Fig. S2A,C).
Microscopy of the internal organs revealed sporadic aggregates of
PMs-PEG in the capillaries of gills (n=3), liver (n=2) and brain
(n=2) of some individuals (total n=9). Such aggregates have the
potential to cause a blockage of the small capillaries. However,
no obvious pathological patterns, such as organ color change or
extensive necroses, were found by visual and microscopic
inspection in these areas (Fig. 3; Fig. S4). A minor hemorrhage
was associated with a cluster of PMs in the fish liver (n=1) (Fig. 3E).
Distribution of PMs-PEG after intramuscular injection
Intramuscular injection was also used to implant PMs-PEG in adult
fishes and investigate the fate and distribution of microcapsules.
Two different sizes of PMs-PEG (median diameters 2.7 and 4.0 µm,
Fig. 1) were used to compare the fates of smaller and larger
PMs-PEG in the tissues.
The fluorescence of intramuscularly injected PMs-PEG was
clearly visible in the images as a bright luminous tunnel left by the
Fig. 2. Representative images of PMs-PEG in capillaries of zebrafish gills. (A-E) 7 days following injection of PMs-PEG into the fish kidney. (F) 1 day following
retro-orbital injection. A shows side view; B shows bottom view; C-F show isolated gill arches. Fluorescent images of PMs-PEG are obtained in green channel.
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needle across the segments of myotomes (Fig. 4). Microcapsules
under the skin were increasingly blurred with depth. At the point of
puncture inlet many bright dots were observed, and it was apparent
that these were PMs-PEG spilt on the skin surface. Thus, to estimate
stability of the fluorescence, we analyzed the region farthest from
the injection inlet (Fig. 4B).
The area of fluorescence at the site of injection decreased with
time (n=9), although the glow was detected at least three
weeks post-injection. During the first week of observation, the
area of fluorescence remained fairly constant in the region of
injection (Fig. 5), with a decrease of approximately 12% in fishes
injected with both 2.7 and 4.0 µm PMs-PEG. At 7 days
after administration, migration of fluorescent dye by phagocytes
was observed (see below), which appeared as clearly visible,
separate fluorescent dots out of the injection tract. This
fluorescence pattern was distributed along regular branched
tracks, which were similar in appearance to the intersegmental
spaces of myotomes. After 14 days, fluorescent objects were
observed at the base of the dorsal fin rays and the base of the anal
fin rays, which are on the opposite side of the fish body in the
ventral direction from the injection site (Fig. 4A). Because the
migrating elements spread out and increased the fluorescent area,
the fluorescence of the migrating elements was subtracted in the
analysis to assess the decreasing rate of fluorescence in the
puncture tunnel only (Fig. 5B).
The size of PMs-PEG did not significantly affect the rates of
decrease of fluorescence in muscles during the observation time.
Fluorescent areas after the introduction of both types of PMs-PEG
continued to decrease at a constant rate of approximately 15-25%
per week. However, microcapsules with an average diameter of
2.7 µm tended to leave the injection site faster than the 3.9 µm
PMs-PEG.
Histological analysis of fish muscles after injection of PMs-
PEG
An injection tract was clearly distinguishable containing foci of
FITC fluorescence on the serial histological sections of fish
muscles. On day 22 after injection, the space of the hollow tract
was filled with a relatively loose tissue, indicating the wound
healing process was in the stage of granulation (Fig. 6). Granulation
tissue is primarily composed of fibroblasts, which in the outer
wound edge deposited collagen fibers and formed zones with dense,
non-nuclear tissue (scar tissue). In more ‘recent’ areas of the wound,
an ongoing process of chronic inflammation was occurring,
characterized by the presence of young fibroblasts and a
significant number of macrophages and lymphocytes removing
Fig. 3. Selected images of aggregates
of PMs-PEG in zebrafish immediately
after injection. (A-C) Gill filaments of D.
rerio following retro-orbital (A,C) or
intrarenal (B) injection. (D,E) Aggregates
of PMs-PEG in a hepatic vessel of some
individuals of D. rerio following retro-
orbital injection. Fluorescent images of
PMs-PEG are obtained in green channel.
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mechanically damaged and necrotic tissues. In the inner zones of the
wound, rounded structures consisting of macrophages tightly
clustered around the aggregated fluorescent microcapsules were
observed (Fig. S5). These structures were typical granulomas
formed as a result of cellular immune response to the introduction of
a foreign body. In some cases, macrophages that surrounded PMs-
PEG fused together, organizing the so-called ‘multinucleated giant
cells’ formation, which encapsulated the implant (Fig. S5E). The
formation of giant cells with subsequent coating with a fibrin
membrane is the final stage in the attempts of the immune system to
eliminate an irritant, and occurs when the foreign body cannot be
degraded and removed from the tissue.
Migration of PMs-PEG outside the injection tract was observed
along the outer walls of blood capillaries between the myomeres,
apparently in lymphatic ducts (Fig. 7A). Despite lymph vessels of
fishes having access to the primary blood system (Fischer and
Steffensen, 2008; Rummer et al., 2014), we did not observe any
microcapsules in capillaries of muscles. Free PMs-PEG were not
observed and were found only as clusters inside phagocytic cells.
Loaded phagocytes had typical bubble structures ofmicrometric size in
their cytoplasm, easily detected by transmission imaging (Fig. 7).
Fluorescent microscopy showed that fluorescence of the dye was
localized inside these spherical structures, indicating thatmicrocapsules
did not lose their integrity in the phagocytes. Microphotographs
showed that by day 22 after injection, loaded phagocytes migrated
beneath the surface of the skin at the base of the fin rays and then
continued to move into the epidermis covering the scales (Fig. 8).
DISCUSSION
Some technical difficulties are associated with application of
polyelectrolyte microcapsules loaded with fluorescent probes for
in vivo sensing. The intensity and stability of the signal should be
sufficient for reliable spectral detection, which require either
sufficient concentration of PMs in the organism fluids or their
accumulation in specific areas of interest. The spread of any particle
in the body depends on the strategy of administration and the
mobility, which is determined by the particle size, form and surface
properties.
In this study, we tested PAH/PSS-based PMs covered with PLL-
g-PEG [poly(L-lysine)-graft-poly(ethylene glycol) co-polymer] as
carriers for a fluorescent indicator. The applied PMs-PEG were
characterized by micrometric size and a flexible shell of nanometers
thickness (Kreft et al., 2007). Particles of such caliber (more
generally, from 0.5 to 100 µm) cannot pass the histo-hematic
barrier (Yuan and Rigor, 2010). Therefore, being administered
intravenously, PMs-PEG cannot leave the circulatory system.
Similarly, when administered interstitially, PMs-PEG cannot be
rapidly washed by blood from the site of injection. Therefore,
microcapsules of this size loaded with an indicator probe are useful
for continuous monitoring or visualization of the circulatory system
(Yashchenok et al., 2016) and interstitial fluids. This caliber of
particle can also be applied in practice for investigation of the
lymphatic system (Andorko et al., 2014), vaccine formulations (De
Geest et al., 2012), therapy of solid cancer (Kennedy, 2014; Shao
et al., 2015) and ‘smart’ tattoo ink fabrications (Ruckh and Clark,
2014). However, some special techniques can be proposed to make
PMs enter (or even pass) the endothelium of blood vessels, for
example, by applying PMs with embedded magnetite nanoparticles
under magnetic field (Voronin et al., 2017).
Previously, Sadovoy et al. (2012) administered 1-2 µm PMs-PEG
in the pericardium of zebrafish embryos and reported that the
manipulation did not cause any disorders of development, which
Fig. 4. Migration of PMs-PEG from the injection tract
following intramuscular injection. (A) Representative image
of D. rerio 14 days following the intramuscular injection of PMs-
PEG (dotted line corresponds to the injection tract). The arrows
indicate fluorescence at the base of the anal fin rays.
(B) Changes in the shape and area of FITC fluorescence in fish
muscles. The frame indicates the analyzed region (see Fig. 5);
the arrow marks the needle puncture inlet. Fluorescent images
of PMs-PEG are obtained in green channel.
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confirmed the possibility of implanting the encapsulated fluorescent
sensors into living organisms. One week after injection, PMs-PEG
were registered in distant fish organs, including the brain, eyes,
endoderm and the spinal cord; and thus, they spread in the
circulatory system. The applied PLL-g-PEG cover was proposed to
significantly improve the biocompatibility of the microcapsules in
comparison with uncovered PMs and decrease the negative effects
of microcapsule administration. Thus, the type of PMs-PEG has
shown desirable properties for implantable sensors: stability of the
shell (non-biodegradable) for long-term observations; shell
flexibility facilitating PM traffic in tight capillaries; and high
biocompatibility. However, in their study, the concentrations used
were not provided, and the allowable concentrations that had no
toxic or teratogenic effect on fish were not established.
Fig. 5. Decrease of FITC fluorescence in fish muscles following injection of PMs-PEG with average diameters of 2.7 (n=5) and 4.0 µm (n=4). (A) Total
fluorescence. (B) Fluorescence in area of injection tract, which is designated by the purple selection on the right.
Fig. 6. Sagittal section of fish muscles of D. rerio
22 days following the intramuscular injection of
PMs-PEG. (A) Transmission image, H&E stain.
(B) Fluorescence image. The arrows indicate
clusters of PMs-PEG surrounded by macrophages
(granulomas); arrowheads indicate normal muscle
tissue composed of regular muscle fibers.
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To investigate toxic potential of PMs-PEG, we introduced a high
concentration of microcapsules into adult D. rerio. Because of the
tiny size of zebrafish, intravenous injection is traumatic; therefore,
microcapsules were injected in the middle portion of the kidney,
which is enriched with capillaries. After successful administration,
PMs-PEG immediately appeared in the gill capillaries and were
easily detected by intravital microscopy after removal of the gill
cover (Fig. 2). Likewise, the fluorescence of PMs-PEG was easily
registerable in this organ in vivo using a spectrometer coupled to a
microscope as described in (Borvinskaya et al., 2017).
Concentrations of PMs-PEG up to 106-107 microcapsules/µl were
used in the experiments, and these concentrations were apparently
the maximum, because at higher suspension concentrations of PMs-
PEG, the lumen of the injection needle began to clog. However,
these concentrations were more than sufficient to introduce enough
PMs-PEG for registration of spectral signal and physiological
measurements. Moreover, the LD50 value for toxic effect was not
reached during these experiments, confirming the low direct toxicity
of PMs-PEG to the adult fish at the level of the organism. However,
with the method of administration (injection in the fish kidney), only
a part of the suspension directly entered into the bloodstream, with
the excess spilling into the body cavity.
The highest death rate of approximately 10-15% was observed
immediately after injection and was most likely associated with the
trauma and stress caused by the procedure. The mortality then did
not exceed that level in either the experimental or control group
(received 0.9% NaCl solution). The type of encapsulated dye
(i.e. FITC-BSA, FITC-Dextran or SNARF-1-Dextran) did not
significantly affect fish mortality.
Micrometric components may pose a risk of obstruction in blood
capillaries. Particles with limited mobility likely begin at the
approximate size of blood cells, which in fishes ranges from 5 to
30 µm depending on the species (Gregory, 2003). Therefore,
particles larger than 30 µm can potentially clog some capillaries and
provoke thrombi and minor strokes. Because the PMs have soft
flexible shells, their mobility is expected to be greater than that for
solid particles of the same diameter. Similarly, the elastic membrane
of red blood cells permits squeezing through tight capillaries
(She et al., 2012). This feature is important for preventing blood
clogs in small capillaries and is one of significant advantages of
PMs. In our study, we observed that 3.9±0.9 μm PMs-PEG easily
traveled through the zebrafish capillaries and, within the first
minutes after injection, spread to the primary fish organs (gills,
liver, kidney and brain) (Fig. 2; Figs S1-S4). However, mortality
tended to be slightly higher in fishes injected with larger PMs-PEG
and lower in fishes injected with microcapsules of smaller
diameter (Table S1).
Microcapsules may form agglomerates with one another and
with blood elements; thus, capillary occlusion most likely caused
higher mortality of fishes injected with PMs-PEG at a
concentration of approximately 4×106/µl than fishes injected
with lower concentrations (Table S1). Although most
microcapsules in the fish organs were distributed one by one
(Fig. 2; Figs S1-S4), single clusters of microcapsules that had the
potential to cause a blockage of the small capillaries were found
during the external examination of zebrafish organs (3 of 9 fishes)
(Fig. 3). However, we did not observe marked blood congestion in
these areas, which indicated that blood elements kept moving
through the capillaries. Therefore, further histological study is
required to determine whether ischemia symptoms occur in the
regions in which such aggregates form.
Obtained results are consistent with a recent in vivo experiment
investigating distribution of 3 μm PMs (with embedded magnetic
nanoparticles) in the mesenteric vessels of rats (Voronin et al.,
2017). PMs tended to aggregate in the bends and bifurcations in the
network of microcapillaries due to blood turbulence slowing down
the blood flow. Histological analysis showed that blood flow in big
vessels remains intact, but PMs block some small mesenteric
vessels. However, it should be noted that this study involved two
factors facilitating the formation of aggregates: no special coverage
was applied to reduce aggregation of PMs, and they were
concentrated in the studied region by external magnetic field.
Fig. 7. Phagocytosis of PMs-PEG in fish muscles 22 days following the intramuscular injection of PMs-PEG. (A) Microsection of D. rerio muscle,
H&E stain. The arrows indicate a capillary filled with erythrocytes. The arrowheads indicatemacrophages loaded with PMs-PEG (cells with granulated cytoplasm)
migrating along the outer walls of blood capillaries in the lymphatic ducts. (B,C,D) Macrophages engulfing PMs-PEG. Note intact microcapsules (arrows)
in the cytoplasm of phagocytes. The nuclei of the cells aremarked with arrowheads. Fluorescence image (D) shows dye localization inside of intactmicrocapsules
in the macrophage cytoplasm.
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Retention in the network of branched and curved capillaries was
shown in our study: over time, PMs-PEG tended to deposit in
capillaries of organs with a rich blood supply (Fig. 2; Figs S2-S3).
Therefore, kidney, gills, liver, spleen and brain are the organs that
may be most affected by the introduction of large concentrations of
microcapsules. The same results were obtained when microcapsules
were injected into the tail vein of mouse (Yi et al., 2014; Shao et al.,
2015). In those studies, accumulation of microcapsules was noted
mainly in capillary-rich liver and spleen, as well as in the vascular
network of tumors, which is a valuable property that allows the use
of PMs for the visualization and treatment of solid cancers (Shao
et al., 2015). The studies on mice do not report any obvious effects
of PMs administered intravenously on morphology of main internal
organs; however, special attention should be paid to assessment of
chronic effects of microcapsules on these organs.
In contrast to systemic injection, microparticles administered
interstitially have low mobility (Tang et al., 2009), and therefore,
stable aggregates are more likely formed in the injection site. Only
for the smallest size range (0.01-1 µm), some migration has been
shown previously due to diffusion into the intercellular space
(Molenda et al., 2008; Khetarpal et al., 2010; Facca et al., 2010).
However, particles in the size range from 0.1 to 6 µm can be
engulfed by phagocytic cells, which then transport the particles to
the draining lymphatic nodes for presentation to T-cells (De Geest
et al., 2006; Molenda et al., 2008; De Koker et al., 2007; Champion
et al., 2008; Matsika et al., 2013; Cheung et al., 2014).
In this study, we observed distribution of the encapsulated
fluorescent dye in fish tissues after intramuscular injection of PMs-
PEG. Fluorescence of the dye was detected at least 3 weeks after
injections, and therefore, during this time, the sensor signal was
registerable (Fig. 4B). During the first week, the coloration was the
most stable; however, a progressive decrease of the fluorescence
occurred during the second and third weeks of the experiment,
accompanied by migration of the fluorescent dye from the injection
site. The decrease of fluorescence could be partly related to
destruction of the microcapsules and leaching of the dye, but this
effect was not investigated. However, a significant part of the
fluorescence decrease was related to the migration of the dye out of
the injection tract, which was caused by transport of microcapsules
by phagocytic cells. The pattern of fluorescence distribution in fish
muscles (Fig. 4) corresponded to the architecture of fish lymphatic
vasculature (Isogai et al., 2009; Okuda et al., 2012). Histological
Fig. 8. Sagittal section of D. rerio 22 days after the intramuscular injection of PMs-PEG. (A) Fish tail with dorsal (upper arrow) and anal fins (lower arrow),
H&E stain. The asterisks indicate the scale pockets; the arrowhead indicates the backbone. (B) Fluorescence image scaled from A shows accumulation of
macrophages loaded with PMs-PEG at the base of the dorsal fin. The arrow indicates the epidermis that covers the scales. Fluorescent images of PMs-PEG are
obtained in green channel. (C) Fluorescence image of clusters of phagocytes loaded with PMs-PEG migrating from the muscle tissue toward the fish skin. The
asterisks indicate the scale pockets; arrowheads indicate the epidermis; red arrows indicate the scale plates. (D) Figure scaled from C showing basophilic
coloration around bone (arrowhead) indicating leucocyte infiltration and inflammation process, H&E stain. (E) Figure scaled from C shows loaded phagocyte
(arrow) in the epidermis of scale, recognized by the granulated cytoplasm, H&E stain.
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analysis confirmed that fish immune cells recognized and attacked
the introduced microcapsules. The PMs-PEG were transported from
the injection site by phagocytic cells along the lymphatic ducts
under the fish skin, and then to the epidermis (Figs 7 and 8). Fish
skin mucosa is an inductive site containing a skin-associated
lymphoid tissue (SALT) represented by secretory cells,
lymphocytes, granulocytes, macrophages, and dendritic cells
(Lugo-Villarino et al., 2010; Salinas et al., 2011; Xu et al., 2013).
Presumably, phagocytes delivered the absorbed microcapsules to
the secondary lymphoid tissue to present the antigen for activation
of antigen-specific leukocytes.
Recognition of uncovered microcapsules by immune cells was
shown earlier in vitro. De Koker and co-workers reported moderate
tissue reaction to the subcutaneous administration of dextran
sulfate/poly-L-arginine-based microcapsules (biodegradable).
Within sixteen days, most of the microcapsules were engulfed by
macrophages and destroyed (De Koker et al., 2007). Sulfate/poly-L-
arginine microcapsules delivered in the pulmonary system to mice
were internalized bymacrophages and dendritic cells, and transported
a long distance to the draining lymph nodes inside the body (De
Koker et al., 2010). PMs composed of PSS and PAH are also
engulfed by phagocytes, but unlike dextran-based microcapsules,
these PMs retain their integrity at least 60 h after cellular uptake and
even after incubation in pronase solution for several days (De Geest
et al., 2006). Similar to De Geest and colleagues, we observed
microcapsules filled with FITC in the cytoplasm of phagocytic cells,
most likely macrophages (Lugo-Villarino et al., 2010). In our study,
the PMs-PEG inside the phagocytes remained intact for at least
22 days after injection, supporting long-term non-biodegradability of
the PAH/PSS/PLL-g-PEG shell.
Extent and rate of phagocytic clearance depend on the size and
surface properties of PMs. The absorption maximum of
macrophages occurs at a particle size of approximately 3 µm
(Champion et al., 2008); thus, the caliber of PMs-PEG used in this
study was presumably subjected to attack by leukocytes. Consistent
with the maximum absorption of macrophages, the 2.7 µm median-
sized PMs-PEG should have been more available for cellular uptake
than those at 4.0 µm. The rate of fluorescence degradation in our
experiment was slightly higher for microcapsules of this lower
caliber, although the difference was not significant.
Tomimic the microcapsules from phagocytes, the PEG coating of
PMs was applied. PEGylation of PMs is typically used to prevent
non-specific protein adsorption, opsonization, and subsequent
cellular uptake (Poon et al., 2011; Morton et al., 2013; Cui et al.,
2014). To immobilize PEG on charged polyelectrolyte
microcapsules, copolymer polyethyleneglycole-grafted poly-L-
lysine (PLL-g-PEG) was applied, as previously suggested
(Heuberger et al., 2005; Sadovoy et al., 2012). Poly-L-lysine
residues adsorb on PSS-terminated microcapsules through
electrostatic interaction, with PEG chains stretched out
perpendicularly to the surface. Wattendorf and coworkers (2008)
demonstrated that PLL-g-PEG coatings on 1.2 and 4.8 µm
microcapsules efficiently shielded them from cellular recognition,
measured by a decline in phagocytosis of PMs by dendritic cells and
macrophages up to 85–90%. Cellular internalization or association
of PLL-g-PEG-coated microcapsules was minor during a 4 h
experiment, in contrast to uncoated PMs or those coated with PLL
only, which were readily incorporated. The PLL-g-PEG coating is
stable for at least 4 weeks in buffer and human serum. No absorption
of serum proteins was detected during storage, and the cellular
recognition of incubated microcapsules by phagocytic cells was
negligible (Wattendorf et al., 2008).
Immune response to PEGylated microcapsules can be caused for
different reasons. Wattendorf and colleagues (2008) noted that even
submicrometer-sized defects in the final PEG layer might lead to
their recognition by phagocytes. Thus, any mechanical deformation
of the microcapsule shell, insufficient PEG density on the surface or
other characteristics that vary from batch-to-batch or within a batch
in the fabrication of PMs-PEG may impair the biocompatibility.
Additionally, PEG, despite poor opsonization, can nevertheless
induce recognition by the immune system through complement
activation (Knop et al., 2010). Therefore, other biomimetic
non-biodegradable alternatives to PEG as terminal cover for PMs
should be tested in vivo (Knop et al., 2010) to prolong the time of
access of encapsulated sensors to intercellular space.
We observed apparent transport of microcapsules by phagocytic
cells only on the second week after intramuscular injection (started
between days 7 and 14). Such delay can be caused by late massive
recognition of microcapsules due to the PEG coverage. We should
mention that activation of immune cells’ response can also be
accelerated by the recruitment of phagocytes to remove debris of
disrupted cells in the healing zone. Thus, we hypothesize that
recognition by the immune system in a living organism could occur
even slower following intravenous administration without wounding.
Therefore, according to our data, the prolonged biocompatibility of
PMs-PEG reported previously (Wattendorf et al., 2008; Sadovoy et al.,
2012) remains in question. Analysis of histological sections showed
that on day 22 post-injection of PMs-PEG into the fish muscles only
small fluorescent foci surrounded by phagocytic cells remained at the
site of the injection, indicating a process of gradual resolution of
microcapsule agglomerates (Fig. 6; Fig. S5). Most of the other space
of the wound was filled with fibroblasts, regenerating blood vessels
and fibrous tissue, which showed that the healing reaction developed
according to a standard scenario. However, the specific morphological
structures of granulomas and foreign-body giant cells indicated
chronic inflammation processes provoked by PMs-PEG. Of note, the
granuloma is an area of active chemical processes involving many
proteases and oxidative enzymes, which must be considered when
interpreting the signal of sensors in this formation.
Conclusions
In the context of evaluation of physiological parameters in vivo, we
administered PEG-covered polyelectrolyte microcapsules to adult
zebrafish in this study to assess potential opportunities and risks
related to application of these carriers for fluorescent sensors. The
following two areas are the focus of discussion: the route of
administration of PMs-PEG and the biological response to
microcapsule insertion. These factors both significantly affect
sensor signal recording and data interpretation.
The route of administration (interstitial or intravenous) determines
the dynamic of distribution of microcapsules in the body. In this
study, PMs-PEG 2-5 µm in diameter delivered into the bloodstream
soon spread through the body and did not cause significant
harmful effects. The administered amounts of PMs-PEG (up to
106-107 microcapsules/µl) were significantly below the LD50 dose
but were absolutely sufficient for visualization and spectral signal
recording for at least one week after injection. The PMs-PEG injected
into muscles had a long half-life elimination period, which was
similar for PMs with the median sizes of 2.7 and 4.0 µm. Phagocytes
recognized microcapsules and actively transported them from the
injection site; however, PMs-PEG retained their stability inside the
phagocytes.
To summarize, the PMs-PEG showed negligible acute toxicity;
however, chronic negative effects, such as induction of
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inflammation, require further consideration. The results obtained in
this study are intended to facilitate further development and
application of this technology for researchers in biological and
medical studies.
MATERIALS AND METHODS
Preparation of PMs-PEG
Fluorescein isothiocyanate (FITC) conjugated with bovine serum albumin
(FITC-BSA, FD20S; Sigma-Aldrich, USA) was used as the fluorescent label
of PMs-PEG due to the intense fluorescence (Ex 494 nm, Em 512 nm) with
high quantum yield (Sjöback et al., 1995). In the toxicity tests, two fluorescent
dyes that conjugated with dextran, SNARF-1 (SNARF-1-Dextran, D3304;
Thermo Fisher Scientific, USA) and rhodamine B isothiocyanate (RITC-
Dextran, R9379; Sigma-Aldrich, USA), were also applied.
Hollow polyelectrolyte microcapsules filled with the fluorescent dyes
were prepared using layer-by-layer assembly as previously described
(Borvinskaya et al., 2017). The selected fluorescent dye was co-precipitated
into cores of calcium carbonate by mixing 2 ml of a fluorescent dye solution
with 0.615 ml of 1 M sodium carbonate and 0.615 ml of 1 M calcium
chloride under stirring for 5 s, followed by washing 3 times in deionized
water. The diameter of synthesized cores defines the size of prepared PMs-
PEG, which varied by 1-2 µm from batch to batch for the same dye and also
depending on the dye. The concentrations of the dyes used were 2.5 mg/ml
for SNARF-1-Dextran, 2 mg/ml for FITC-Dextran and 1.2-2.5 mg/ml
(depending on batch) for FITC-BSA. The prepared porous cores were then
covered with 12 layers of oppositely charged polyelectrolytes: positive poly
(allylamine hydrochloride) (PAH, 283215; Sigma-Aldrich, USA) and
negative poly(sodium 4-styrenesulfonate) (PSS, 243051; Sigma-Aldrich,
Belgium). Poly(L-lysine)-graft-poly(ethylene glycol) co-polymer (PLL-g-
PEG, SZ34-67; SuSoS, Switzerland) was deposited as the final layer
(Sadovoy et al., 2012). After dissolving the calcium carbonate cores in
0.1 M EDTA solution (pH 7.0), the structure of the PMs-PEG followed the
formula (PAH/PSS)6/PLL-g-PEG with the selected fluorescent dye inside.
Concentrations of PMs-PEG and their diameters were evaluated using a
counting chamber (hemocytometer). The images of PMs-PEG were
obtained under a fluorescent microscope Mikmed-2 (LOMO, Russia) with
an EOS 1200D camera (Canon, Japan) and analyzed using ImageJ 1.50d
(NIH) (Schneider et al., 2012).
Animals and housing
Adults of Danio rerio approximately 2.6 cm long and 0.3 g in weight were
purchased in a local pet store and kept in polypropylene plastic tanks (1 fish
per liter) filled with commercial bottled water from Lake Baikal. Fish were
fed once a day with TetraMin commercial feed (Tetra Werke, Germany).
Proper hydrochemistry was maintained by daily replacement of 20% of the
water. Ammonium, nitrites and nitrates in the water were measured using
semiquantitative commercial aquarium tests [Nilpa (Neva Tropic, Russia);
Tetra (Tetra Werke, Germany)] and did not exceed 1, 0.3, and 12.5 mg/l,
respectively.Water pH during experiments was 7.34-7.86, dissolved oxygen
was maintained at 5-8 mg/l, and water temperature was approximately
19-20°С.
Injections of PMs-PEG
PMs-PEG were delivered into the bloodstream of D. rerio by either
intrarenal or retro-orbital injections, whereas intramuscular injections were
performed to administer microcapsules interstitially. The work was
conducted in accordance with the EU Directive 2010/63/EU for animal
experiments and has been approved by the Animal Subjects Research
Committee of Institute of Biology at Irkutsk State University. Before the
injection procedure, each fish was individually immersed into 0.0002%
methylene blue solution for 1.5 min to avoid the development of infections.
After this treatment, fish were anesthetized for 1 min in clove oil suspended
in water (0.1 ml/l), weighed and immobilized on a wet sponge (Cheung
et al., 2014). Suspensions with different concentrations of PMs-PEG in
sterile 0.9% NaCl solution were injected using a 31 G needle (Ø 0.25 mm)
connected to a microinjector IM-9B (Narishige, Japan).
To introduce PMs-PEG into bloodstream, injections into a central bulge
of the fish trunk kidney were performed in the middle of abdomen
immediately under the lateral line. During the injection, the needle
mechanically damaged renal parenchyma that is rich in capillaries and
blood vessels, which allowed PMs-PEG entrance into the circulatory
system. The introduction of PMs by retro-orbital injection was the second
method of delivery into the fish bloodstream (Pugach et al., 2009). However,
because this technique did not show satisfactory effectiveness during
pretests, retro-orbital injection was not used further for PMs-PEG toxicity
testing.
Treated fishes were rinsed with water, and then with surgical scissors, one
operculum was excised. The success of the PMs-PEG delivery into the
bloodstream was monitored by rapid inspection of denuded gills for
fluorescent particles. In case of a successful injection, fluorescent PMs-PEG
appeared immediately in the gills (see e.g. Fig. 2). For recovery, fishes were
placed in tanks with aeration. The entire procedure required an average of
3-5 min per one fish.
Intramuscular injections were performed by puncture in the dorsal part of
the tail ofD. rerio. The needle was introduced at approximately 5 mm in the
cranial direction along the dorsal fin, approximately 0.1-0.5 mm beneath the
skin. After the procedure, fishes were rinsed with water to remove spilled
suspension of PMs-PEG (if any), imaged and returned into their holding
tanks for recovery.
Organism-level toxicity examination
To evaluate acute and chronic effects of PMs-PEG administration, fishes
were injected in the kidney with suspensions (1.6-2 µl) of various
concentrations of PMs-PEG (4×103-6×106) of various sizes (average Ø
2.0-5.1 µl) and filled with several fluorescent dyes (Table S1). After the
procedure, fishes were placed in a holding aquarium and monitored for up to
22 days. Deaths of fishes were recorded after the injection (when the fish did
not recover within 30 min after anesthesia) and then once a day. In the
controls of the experiment, fish received a 0.9% solution of NaCl instead of
PMs-PEG suspension.
Investigation of PMs-PEG distribution in the bloodstream
To study tissue distribution of PMs-PEG through the circulatory system, six
individuals of D. rerio were injected into the kidney and three individuals
received retro-orbital injections (Pugach et al., 2009). The injections were
1.6 µl of suspension of 7×105 PMs-PEG per µl with a size of 3.9±0.9 µm
(median=3.97 µm) and containing FITC-BSA (Fig. 1A). Three individuals
(two injected into the kidney and one retro-orbitally) were sacrificed
immediately after injection (0 day) and then at days 3 and 7 by immersion in
0.5 ml/l clove oil-water suspension for 10 min. The general inspection and
imaging of fish were performed using a BX53 fluorescent microscope
(Olympus, Japan) with D7100 camera (Nikon, Japan) or an SPM0880 zoom
stereomicroscope (Altami, Russia) with U3CMOS05100KPA camera
(Altami, Russia) and a blue laser (445 nm) coupled with optical fiber OV-
KS0600-08 (Altami, Russia) for fluorescence excitation. Then, fish organs
(gills, heart, liver, kidney and brain) were dissected (Gupta and Mullins,
2010), washed in saline, transferred onto glass slides, covered by glass
coverslips and viewed under a Mikmed-2 fluorescent microscope (LOMO,
Russia) with 1200D camera (Canon, Japan). Representative photos, if
necessary, were automatically stacked or stitched in a panoramas using
Adobe Photoshop CC software.
Investigation of PMs-PEG distribution and stability after
intramuscular injection
Two sizes of PMs-PEG, 3.9±0.9 µm (median=3.97 µm) and 2.7±0.6 µm
(median=2.74 µm), were used for intramuscular injections (Fig. 1A and B,
respectively). Concentration of PMs-PEG was adjusted for the fish from
both groups (n=4 and 5) to receive approximately the same amount of dye
(0.01 µg of dye per 1 μl of PMs-PEG suspension).
To determine the stability of fluorescence in the site of injection, all
individuals were photographed immediately after the manipulation and on
days 1, 3, 7, 14 and 22 post-injection. Before each examination, fish were
anesthetized in a water suspension of clove oil (0.1 ml/l for 1 min). All
photographs were taken using a 1200D camera (Canon, Japan) connected to
a Mikmed-2 fluorescent microscope (LOMO, Russia) with identical camera
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settings and magnification. The digital photos were merged and stacked
automatically using Adobe Photoshop CC software. Selection of a colored
region and calculation of the area (number of saturated pixels in the green
channel) were conducted in the same program using the built-in
measurement tools by unified procedure.
To prepare Fig. 5, an additional package beeswarm (Eklund, 2016) for R
(R Core Team, 2017) was used. The linear regression was built with the
intercept forced to equal 100. The difference in rates of fluorescence
degradation between PMs-PEG of different sizes was verified at each time
point using the Mann–Whitney U-test with correction for multiple
comparisons according to Hommel in R (R Core Team, 2017).
Histological examination
For histological analysis, individual zebrafish were sacrificed 22 days after
intramuscular injection in 0.5 ml/l clove oil-water suspension for 10 min.
After removal of head and tail, fish bodies were dissected in half
transversely and fixed in Bouin’s solution (Sigma-Aldrich) at 25°C for
1 day. On the next day, samples were rinsed in tap water for one hour and
stored in 10% neutral buffered formaldehyde. Biological specimens were
embedded in paraffin routinely using an STP 120 Spin Tissue Processor
(Thermo Fisher Scientific, USA) according to the protocol for fish tissues
(Mikodina et al., 2009). Paraffin molds were sectioned at 6 μm in thickness
by an HM-440 microtome (Thermo Fisher Scientific, USA). Tissue slides
were first deparaffinized, then inspected by fluorescent microscopy using an
Olympus CX61 microscope to detect PMs-PEG (since eosin has
fluorescence spectra similar to that of FITC). The localization of the
detected PMs-PEG was verified in series of adjacent sections for all samples
to avoid possible misinterpretation of artifacts caused by the displacement of
particles during cutting. Finally sections were stained with hematoxylin and
eosin by standard procedure. Stained sections were studied under a light
microscope and photographed with a D7100 camera (Nikon, Japan)
connected to the microscope.
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Möhwald, H. (2003). Carbonatemicroparticles for hollow polyelectrolyte capsules
fabrication. Colloids Surf. A 224, 175-183.
Borvinskaya, E., Gurkov, A., Shchapova, E., Baduev, B., Shatilina, Z., Sadovoy,
A., Meglinski, I. and Timofeyev, M. (2017). Parallel in vivo monitoring of pH in gill
capillaries andmuscles of fishes usingmicroencapsulated biomarkers.Biol. Open
6, 673-677.
Champion, J. A., Walker, A. and Mitragotri, S. (2008). Role of particle size in
phagocytosis of polymeric microspheres. Pharm. Res. 25, 1815-1821.
Cheung, E., Chatterjee, D. and Gerlai, R. (2014). Subcutaneous dye injection for
marking and identification of individual adult zebrafish (Danio rerio) in behavioral
studies. Behav. Res. Methods 46, 619-624.
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